| Pembrolizumab 100 MG/4ML Solution 4.000 ML UDAntineoplastics and Adjunctive Therapies | 00006302602 | $4,156,458 (Total acquisition cost of Pembrolizumab 100 MG/4ML Solution 4.000 ML UD, page 7 of the report PDF) | $1,737,661 (Total estimated savings of Pembrolizumab 100 MG/4ML Solution 4.000 ML UD, page 7 of the report PDF) | 1 (Hospitals that named Pembrolizumab 100 MG/4ML Solution 4.000 ML UD, page 7 of the report PDF) |
|---|
| OnabotulinumtoxinA 100 UNIT Solution Reconstituted 1.000 EA UDNeuromuscular Agents - Neuromuscular Agents | 00023114501 | $2,194,370 (Total acquisition cost of OnabotulinumtoxinA 100 UNIT Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | $900,606 (Total estimated savings of OnabotulinumtoxinA 100 UNIT Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | 2 (Hospitals that named OnabotulinumtoxinA 100 UNIT Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) |
|---|
| Infliximab-abda 100 MG Solution Reconstituted 1.000 EA UDGastrointestinal Agents - Misc | 78206016201 | $777,210 (Total acquisition cost of Infliximab-abda 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | $573,252 (Total estimated savings of Infliximab-abda 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | 3 (Hospitals that named Infliximab-abda 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) |
|---|
| Elosulfase Alfa 5 MG/5ML Solution 5.000 ML UDEndocrine and Metabolic Agents - Misc | 68135010001 | $629,595 (Total acquisition cost of Elosulfase Alfa 5 MG/5ML Solution 5.000 ML UD, page 7 of the report PDF) | $221,425 (Total estimated savings of Elosulfase Alfa 5 MG/5ML Solution 5.000 ML UD, page 7 of the report PDF) | 1 (Hospitals that named Elosulfase Alfa 5 MG/5ML Solution 5.000 ML UD, page 7 of the report PDF) |
|---|
| Infliximab 100 MG Solution Reconstituted 1.000 EA UDGastrointestinal Agents - Misc | 57894003001 | $578,646 (Total acquisition cost of Infliximab 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | $2,081,635 (Total estimated savings of Infliximab 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | 4 (Hospitals that named Infliximab 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) |
|---|
| Apixaban 5 MG Tablet 60.000 EAHematological Agents - Anticoagulants | 00003089421 | $524,336 (Total acquisition cost of Apixaban 5 MG Tablet 60.000 EA, page 7 of the report PDF) | $1,240,088 (Total estimated savings of Apixaban 5 MG Tablet 60.000 EA, page 7 of the report PDF) | 6 (Hospitals that named Apixaban 5 MG Tablet 60.000 EA, page 7 of the report PDF) |
|---|
| Infliximab 100 MG Solution Reconstituted 1.000 EA UDGastrointestinal Agents - Misc | 57894016001 | $452,722 (Total acquisition cost of Infliximab 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | $233,583 (Total estimated savings of Infliximab 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | 4 (Hospitals that named Infliximab 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) |
|---|
| Semaglutide 2 MG/3ML Solution Pen-injector 3.000 ML UUEndocrine and Metabolic Agents - Antidiabetics | 00169418113 | $107,969 (Total acquisition cost of Semaglutide 2 MG/3ML Solution Pen-injector 3.000 ML UU, page 7 of the report PDF) | $51,424 (Total estimated savings of Semaglutide 2 MG/3ML Solution Pen-injector 3.000 ML UU, page 7 of the report PDF) | 1 (Hospitals that named Semaglutide 2 MG/3ML Solution Pen-injector 3.000 ML UU, page 7 of the report PDF) |
|---|
| Semaglutide 4 MG/3ML Solution Pen-injector 3.000 ML UUEndocrine and Metabolic Agents - Antidiabetics | 00169413013 | $96,431 (Total acquisition cost of Semaglutide 4 MG/3ML Solution Pen-injector 3.000 ML UU, page 7 of the report PDF) | $42,145 (Total estimated savings of Semaglutide 4 MG/3ML Solution Pen-injector 3.000 ML UU, page 7 of the report PDF) | 1 (Hospitals that named Semaglutide 4 MG/3ML Solution Pen-injector 3.000 ML UU, page 7 of the report PDF) |
|---|
| Ferumoxytol 510 MG/17ML Solution 17.000 ML UDHematological Agents - Hematopoietic Agents | 00781315401 | $87,851 (Total acquisition cost of Ferumoxytol 510 MG/17ML Solution 17.000 ML UD, page 7 of the report PDF) | $8,285 (Total estimated savings of Ferumoxytol 510 MG/17ML Solution 17.000 ML UD, page 7 of the report PDF) | 1 (Hospitals that named Ferumoxytol 510 MG/17ML Solution 17.000 ML UD, page 7 of the report PDF) |
|---|
| Denosumab 60 MG/ML Solution Prefilled Syringe 1.000 ML UDEndocrine and Metabolic Agents - Misc | 55513071001 | $59,621 (Total acquisition cost of Denosumab 60 MG/ML Solution Prefilled Syringe 1.000 ML UD, page 7 of the report PDF) | $170,690 (Total estimated savings of Denosumab 60 MG/ML Solution Prefilled Syringe 1.000 ML UD, page 7 of the report PDF) | 1 (Hospitals that named Denosumab 60 MG/ML Solution Prefilled Syringe 1.000 ML UD, page 7 of the report PDF) |
|---|
| Remdesivir 100 MG Solution Reconstituted 1.000 EA UDAnti-Infective Agents - Antivirals | 61958290102 | $59,249 (Total acquisition cost of Remdesivir 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | $37,329 (Total estimated savings of Remdesivir 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) | 1 (Hospitals that named Remdesivir 100 MG Solution Reconstituted 1.000 EA UD, page 7 of the report PDF) |
|---|
| Ferric Carboxymaltose 750 MG/15ML Solution 15.000 ML UDHematological Agents - Hematopoietic Agents | 00517065001 | $47,308 (Total acquisition cost of Ferric Carboxymaltose 750 MG/15ML Solution 15.000 ML UD, page 7 of the report PDF) | $28,201 (Total estimated savings of Ferric Carboxymaltose 750 MG/15ML Solution 15.000 ML UD, page 7 of the report PDF) | 1 (Hospitals that named Ferric Carboxymaltose 750 MG/15ML Solution 15.000 ML UD, page 7 of the report PDF) |
|---|
| Propofol 200 MG/20ML Emulsion 20.000 ML UDGeneral Anesthetics | 25021060820 | $29,311 (Total acquisition cost of Propofol 200 MG/20ML Emulsion 20.000 ML UD, page 8 of the report PDF) | $11,006 (Total estimated savings of Propofol 200 MG/20ML Emulsion 20.000 ML UD, page 8 of the report PDF) | 1 (Hospitals that named Propofol 200 MG/20ML Emulsion 20.000 ML UD, page 8 of the report PDF) |
|---|
| Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 18.000 GM UUAntihistamines/Nasal Agents/Cough and Cold/Respiratory/Misc - Antiasthmatic and Bronchodilator Agents | 66993001968 | $19,264 (Total acquisition cost of Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 18.000 GM UU, page 8 of the report PDF) | $20,517 (Total estimated savings of Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 18.000 GM UU, page 8 of the report PDF) | 3 (Hospitals that named Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 18.000 GM UU, page 8 of the report PDF) |
|---|
| Iohexol 300 MG/ML Solution 100.000 ML UDDiagnostic Products | 00407141363 | $17,022 (Total acquisition cost of Iohexol 300 MG/ML Solution 100.000 ML UD, page 8 of the report PDF) | $42,685 (Total estimated savings of Iohexol 300 MG/ML Solution 100.000 ML UD, page 8 of the report PDF) | 1 (Hospitals that named Iohexol 300 MG/ML Solution 100.000 ML UD, page 8 of the report PDF) |
|---|
| Lactated Ringer's Solution 1000.000 ML UDNutritional Products - Minerals & Electrolytes | 00264775000 | $14,323 (Total acquisition cost of Lactated Ringer's Solution 1000.000 ML UD, page 8 of the report PDF) | $12,207 (Total estimated savings of Lactated Ringer's Solution 1000.000 ML UD, page 8 of the report PDF) | 1 (Hospitals that named Lactated Ringer's Solution 1000.000 ML UD, page 8 of the report PDF) |
|---|
| Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 8.500 GM UUAntihistamines/Nasal Agents/Cough and Cold/Respiratory/Misc - Antiasthmatic and Bronchodilator Agents | 68180096301 | $11,894 (Total acquisition cost of Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 8.500 GM UU, page 8 of the report PDF) | $19,725 (Total estimated savings of Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 8.500 GM UU, page 8 of the report PDF) | 5 (Hospitals that named Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 8.500 GM UU, page 8 of the report PDF) |
|---|
| Amphotericin B Liposome 50 MG Suspension Reconstituted 1.000 EA UDAnti-Infective Agents - Antifungals | 62756023301 | $8,525 (Total acquisition cost of Amphotericin B Liposome 50 MG Suspension Reconstituted 1.000 EA UD, page 8 of the report PDF) | $24,242 (Total estimated savings of Amphotericin B Liposome 50 MG Suspension Reconstituted 1.000 EA UD, page 8 of the report PDF) | 1 (Hospitals that named Amphotericin B Liposome 50 MG Suspension Reconstituted 1.000 EA UD, page 8 of the report PDF) |
|---|
| Pantoprazole Sodium 40 MG Tablet Delayed Release 90.000 EAGastrointestinal Agents - Ulcer Drugs/Antispasmodics/Anticholinergics | 65862056090 | $7,169 (Total acquisition cost of Pantoprazole Sodium 40 MG Tablet Delayed Release 90.000 EA, page 8 of the report PDF) | $160,459 (Total estimated savings of Pantoprazole Sodium 40 MG Tablet Delayed Release 90.000 EA, page 8 of the report PDF) | 1 (Hospitals that named Pantoprazole Sodium 40 MG Tablet Delayed Release 90.000 EA, page 8 of the report PDF) |
|---|
| Oxycodone HCl 5 MG Tablet 100.000 EAAnalgesics - Opioid | 00406055201 | $6,069 (Total acquisition cost of Oxycodone HCl 5 MG Tablet 100.000 EA, page 8 of the report PDF) | $15,533 (Total estimated savings of Oxycodone HCl 5 MG Tablet 100.000 EA, page 8 of the report PDF) | 1 (Hospitals that named Oxycodone HCl 5 MG Tablet 100.000 EA, page 8 of the report PDF) |
|---|
| Palonosetron HCl 0.25 MG/5ML Solution 5.000 ML UDGastrointestinal Agents - Antiemetics | 60505619301 | $5,706 (Total acquisition cost of Palonosetron HCl 0.25 MG/5ML Solution 5.000 ML UD, page 8 of the report PDF) | $73,515 (Total estimated savings of Palonosetron HCl 0.25 MG/5ML Solution 5.000 ML UD, page 8 of the report PDF) | 2 (Hospitals that named Palonosetron HCl 0.25 MG/5ML Solution 5.000 ML UD, page 8 of the report PDF) |
|---|
| Sodium Chloride 0.9 % Solution 1000.000 ML UDNutritional Products - Minerals and Electrolytes | 00990798309 | $5,505 (Total acquisition cost of Sodium Chloride 0.9 % Solution 1000.000 ML UD, page 8 of the report PDF) | $1,812 (Total estimated savings of Sodium Chloride 0.9 % Solution 1000.000 ML UD, page 8 of the report PDF) | 1 (Hospitals that named Sodium Chloride 0.9 % Solution 1000.000 ML UD, page 8 of the report PDF) |
|---|
| Propofol 200 MG/20ML Emulsion 20.000 ML UDGeneral Anesthetics | 63323026929 | $5,448 (Total acquisition cost of Propofol 200 MG/20ML Emulsion 20.000 ML UD, page 8 of the report PDF) | $25,027 (Total estimated savings of Propofol 200 MG/20ML Emulsion 20.000 ML UD, page 8 of the report PDF) | 2 (Hospitals that named Propofol 200 MG/20ML Emulsion 20.000 ML UD, page 8 of the report PDF) |
|---|
| Apixaban 2.5 MG Tablet 60.000 EAHematological Agents - Anticoagulants | 00003089321 | $5,428 (Total acquisition cost of Apixaban 2.5 MG Tablet 60.000 EA, page 8 of the report PDF) | $108,904 (Total estimated savings of Apixaban 2.5 MG Tablet 60.000 EA, page 8 of the report PDF) | 3 (Hospitals that named Apixaban 2.5 MG Tablet 60.000 EA, page 8 of the report PDF) |
|---|
| Triamcinolone Acetonide 40 MG/ML Suspension 1.000 ML UDEndocrine and Metabolic Agents - Corticosteroids | 00703024101 | $3,548 (Total acquisition cost of Triamcinolone Acetonide 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) | $132 (Total estimated savings of Triamcinolone Acetonide 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) | 2 (Hospitals that named Triamcinolone Acetonide 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) |
|---|
| Omeprazole 20 MG Capsule Delayed Release 100.000 EAGastrointestinal Agents - Ulcer Drugs/Antispasmodics/Anticholinergics | 55111015801 | $3,525 (Total acquisition cost of Omeprazole 20 MG Capsule Delayed Release 100.000 EA, page 8 of the report PDF) | $131,515 (Total estimated savings of Omeprazole 20 MG Capsule Delayed Release 100.000 EA, page 8 of the report PDF) | 1 (Hospitals that named Omeprazole 20 MG Capsule Delayed Release 100.000 EA, page 8 of the report PDF) |
|---|
| Methylprednisolone Acetate 40 MG/ML Suspension 1.000 ML UDEndocrine and Metabolic Agents - Corticosteroids | 70121157301 | $2,621 (Total acquisition cost of Methylprednisolone Acetate 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) | $2,931 (Total estimated savings of Methylprednisolone Acetate 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) | 1 (Hospitals that named Methylprednisolone Acetate 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) |
|---|
| Pantoprazole Sodium 40 MG Tablet Delayed Release 1000.000 EAGastrointestinal Agents - Ulcer Drugs/Antispasmodics/Anticholinergics | 65862056099 | $1,943 (Total acquisition cost of Pantoprazole Sodium 40 MG Tablet Delayed Release 1000.000 EA, page 8 of the report PDF) | $746 (Total estimated savings of Pantoprazole Sodium 40 MG Tablet Delayed Release 1000.000 EA, page 8 of the report PDF) | 1 (Hospitals that named Pantoprazole Sodium 40 MG Tablet Delayed Release 1000.000 EA, page 8 of the report PDF) |
|---|
| Triamcinolone Acetonide 40 MG/ML Suspension 1.000 ML UDEndocrine and Metabolic Agents - Corticosteroids | 00003029305 | $1,832 (Total acquisition cost of Triamcinolone Acetonide 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) | $2,657 (Total estimated savings of Triamcinolone Acetonide 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) | 1 (Hospitals that named Triamcinolone Acetonide 40 MG/ML Suspension 1.000 ML UD, page 8 of the report PDF) |
|---|
| Acetaminophen 325 MG Tablet 100.000 EA UDAnalgesics - Nonnarcotic | 00904677361 | $1,531 (Total acquisition cost of Acetaminophen 325 MG Tablet 100.000 EA UD, page 8 of the report PDF) | $1,621 (Total estimated savings of Acetaminophen 325 MG Tablet 100.000 EA UD, page 8 of the report PDF) | 1 (Hospitals that named Acetaminophen 325 MG Tablet 100.000 EA UD, page 8 of the report PDF) |
|---|
| Atorvastatin Calcium 20 MG Tablet 1000.000 EACardiovascular Agents - Antihyperlipidemics | 70377007813 | $1,089 (Total acquisition cost of Atorvastatin Calcium 20 MG Tablet 1000.000 EA, page 8 of the report PDF) | $8,913 (Total estimated savings of Atorvastatin Calcium 20 MG Tablet 1000.000 EA, page 8 of the report PDF) | 1 (Hospitals that named Atorvastatin Calcium 20 MG Tablet 1000.000 EA, page 8 of the report PDF) |
|---|
| Amoxicillin & Pot Clavulanate 875-125 MG Tablet 20.000 EAAnti-Infective Agents - Penicillins | 65862050320 | $983 (Total acquisition cost of Amoxicillin & Pot Clavulanate 875-125 MG Tablet 20.000 EA, page 8 of the report PDF) | $2,555 (Total estimated savings of Amoxicillin & Pot Clavulanate 875-125 MG Tablet 20.000 EA, page 8 of the report PDF) | 1 (Hospitals that named Amoxicillin & Pot Clavulanate 875-125 MG Tablet 20.000 EA, page 8 of the report PDF) |
|---|
| Gabapentin 300 MG Capsule 1000.000 EANeuromuscular Agents - Anticonvulsants | 50228018010 | $945 (Total acquisition cost of Gabapentin 300 MG Capsule 1000.000 EA, page 8 of the report PDF) | $4,927 (Total estimated savings of Gabapentin 300 MG Capsule 1000.000 EA, page 8 of the report PDF) | 1 (Hospitals that named Gabapentin 300 MG Capsule 1000.000 EA, page 8 of the report PDF) |
|---|
| Pantoprazole Sodium 40 MG Tablet Delayed Release 1000.000 EAGastrointestinal Agents - Ulcer Drugs/Antispasmodics/Anticholinergics | 00378668910 | $732 (Total acquisition cost of Pantoprazole Sodium 40 MG Tablet Delayed Release 1000.000 EA, page 8 of the report PDF) | $5,857 (Total estimated savings of Pantoprazole Sodium 40 MG Tablet Delayed Release 1000.000 EA, page 8 of the report PDF) | 1 (Hospitals that named Pantoprazole Sodium 40 MG Tablet Delayed Release 1000.000 EA, page 8 of the report PDF) |
|---|
| Pancrelipase (Lipase-Protease-Amylase) 36000- 114000 UNIT Capsule Delayed Release Particles 100.000 EA UUGastrointestinal Agents - Digestive Aids | 00032301613 | $725 (Total acquisition cost of Pancrelipase (Lipase-Protease-Amylase) 36000- 114000 UNIT Capsule Delayed Release Particles 100.000 EA UU, page 9 of the report PDF) | $933,096 (Total estimated savings of Pancrelipase (Lipase-Protease-Amylase) 36000- 114000 UNIT Capsule Delayed Release Particles 100.000 EA UU, page 9 of the report PDF) | 1 (Hospitals that named Pancrelipase (Lipase-Protease-Amylase) 36000- 114000 UNIT Capsule Delayed Release Particles 100.000 EA UU, page 9 of the report PDF) |
|---|
| Metformin HCl 500 MG Tablet Extended Release 24 Hour 500.000 EAEndocrine and Metabolic Agents - Antidiabetics | 67877015905 | $594 (Total acquisition cost of Metformin HCl 500 MG Tablet Extended Release 24 Hour 500.000 EA, page 9 of the report PDF) | $620 (Total estimated savings of Metformin HCl 500 MG Tablet Extended Release 24 Hour 500.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Metformin HCl 500 MG Tablet Extended Release 24 Hour 500.000 EA, page 9 of the report PDF) |
|---|
| Metformin HCl 1000 MG Tablet 100.000 EAEndocrine and Metabolic Agents - Antidiabetics | 65862001001 | $569 (Total acquisition cost of Metformin HCl 1000 MG Tablet 100.000 EA, page 9 of the report PDF) | $850 (Total estimated savings of Metformin HCl 1000 MG Tablet 100.000 EA, page 9 of the report PDF) | 2 (Hospitals that named Metformin HCl 1000 MG Tablet 100.000 EA, page 9 of the report PDF) |
|---|
| Proparacaine HCl 0.5 % Solution 15.000 ML UUOphthalmic Agents | 61314001601 | $469 (Total acquisition cost of Proparacaine HCl 0.5 % Solution 15.000 ML UU, page 9 of the report PDF) | $1,153 (Total estimated savings of Proparacaine HCl 0.5 % Solution 15.000 ML UU, page 9 of the report PDF) | 1 (Hospitals that named Proparacaine HCl 0.5 % Solution 15.000 ML UU, page 9 of the report PDF) |
|---|
| Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 8.000 GM UUAntihistamines/Nasal Agents/Cough and Cold/Respiratory/Misc - Antiasthmatic and Bronchodilator Agents | 00173068224 | $373 (Total acquisition cost of Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 8.000 GM UU, page 9 of the report PDF) | $997 (Total estimated savings of Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 8.000 GM UU, page 9 of the report PDF) | 1 (Hospitals that named Albuterol Sulfate 108 (90 Base) MCG/ACT Aerosol Solution 8.000 GM UU, page 9 of the report PDF) |
|---|
| Bacitracin (Topical) 500 UNIT/GM Ointment 30.000 GM UUDermatologicals | 00536125628 | $360 (Total acquisition cost of Bacitracin (Topical) 500 UNIT/GM Ointment 30.000 GM UU, page 9 of the report PDF) | $170 (Total estimated savings of Bacitracin (Topical) 500 UNIT/GM Ointment 30.000 GM UU, page 9 of the report PDF) | 1 (Hospitals that named Bacitracin (Topical) 500 UNIT/GM Ointment 30.000 GM UU, page 9 of the report PDF) |
|---|
| Metformin HCl 500 MG Tablet Extended Release 24 Hour 500.000 EAEndocrine and Metabolic Agents - Antidiabetics | 70010049105 | $330 (Total acquisition cost of Metformin HCl 500 MG Tablet Extended Release 24 Hour 500.000 EA, page 9 of the report PDF) | $718 (Total estimated savings of Metformin HCl 500 MG Tablet Extended Release 24 Hour 500.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Metformin HCl 500 MG Tablet Extended Release 24 Hour 500.000 EA, page 9 of the report PDF) |
|---|
| Methylprednisolone Acetate 40 MG/ML Suspension 1.000 ML UDEndocrine and Metabolic Agents - Corticosteroids | 00009307301 | $329 (Total acquisition cost of Methylprednisolone Acetate 40 MG/ML Suspension 1.000 ML UD, page 9 of the report PDF) | $103 (Total estimated savings of Methylprednisolone Acetate 40 MG/ML Suspension 1.000 ML UD, page 9 of the report PDF) | 1 (Hospitals that named Methylprednisolone Acetate 40 MG/ML Suspension 1.000 ML UD, page 9 of the report PDF) |
|---|
| Metformin HCl 500 MG Tablet 100.000 EAEndocrine and Metabolic Agents - Antidiabetics | 65862000801 | $271 (Total acquisition cost of Metformin HCl 500 MG Tablet 100.000 EA, page 9 of the report PDF) | $329 (Total estimated savings of Metformin HCl 500 MG Tablet 100.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Metformin HCl 500 MG Tablet 100.000 EA, page 9 of the report PDF) |
|---|
| Gabapentin 100 MG Capsule 500.000 EANeuromuscular Agents - Anticonvulsants | 67877022205 | $217 (Total acquisition cost of Gabapentin 100 MG Capsule 500.000 EA, page 9 of the report PDF) | $318 (Total estimated savings of Gabapentin 100 MG Capsule 500.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Gabapentin 100 MG Capsule 500.000 EA, page 9 of the report PDF) |
|---|
| Atorvastatin Calcium 40 MG Tablet 90.000 EACardiovascular Agents - Antihyperlipidemics | 72205002490 | $162 (Total acquisition cost of Atorvastatin Calcium 40 MG Tablet 90.000 EA, page 9 of the report PDF) | $648 (Total estimated savings of Atorvastatin Calcium 40 MG Tablet 90.000 EA, page 9 of the report PDF) | 2 (Hospitals that named Atorvastatin Calcium 40 MG Tablet 90.000 EA, page 9 of the report PDF) |
|---|
| Omeprazole 40 MG Capsule Delayed Release 1000.000 EAGastrointestinal Agents - Ulcer Drugs/Antispasmodics/Anticholinergics | 68462039710 | $150 (Total acquisition cost of Omeprazole 40 MG Capsule Delayed Release 1000.000 EA, page 9 of the report PDF) | $7,112 (Total estimated savings of Omeprazole 40 MG Capsule Delayed Release 1000.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Omeprazole 40 MG Capsule Delayed Release 1000.000 EA, page 9 of the report PDF) |
|---|
| Atorvastatin Calcium 80 MG Tablet 90.000 EACardiovascular Agents - Antihyperlipidemics | 72205002590 | $121 (Total acquisition cost of Atorvastatin Calcium 80 MG Tablet 90.000 EA, page 9 of the report PDF) | $425 (Total estimated savings of Atorvastatin Calcium 80 MG Tablet 90.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Atorvastatin Calcium 80 MG Tablet 90.000 EA, page 9 of the report PDF) |
|---|
| Sertraline HCl 100 MG Tablet 30.000 EACentral Nervous System Agents - Antidepressants | 65862001330 | $115 (Total acquisition cost of Sertraline HCl 100 MG Tablet 30.000 EA, page 9 of the report PDF) | $291 (Total estimated savings of Sertraline HCl 100 MG Tablet 30.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Sertraline HCl 100 MG Tablet 30.000 EA, page 9 of the report PDF) |
|---|
| Omeprazole 20 MG Capsule Delayed Release 1000.000 EAGastrointestinal Agents - Ulcer Drugs/Antispasmodics/Anticholinergics | 68462039610 | $112 (Total acquisition cost of Omeprazole 20 MG Capsule Delayed Release 1000.000 EA, page 9 of the report PDF) | $4,035 (Total estimated savings of Omeprazole 20 MG Capsule Delayed Release 1000.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Omeprazole 20 MG Capsule Delayed Release 1000.000 EA, page 9 of the report PDF) |
|---|
| Sertraline HCl 50 MG Tablet 500.000 EACentral Nervous System Agents - Antidepressants | 70010020405 | $67 (Total acquisition cost of Sertraline HCl 50 MG Tablet 500.000 EA, page 9 of the report PDF) | $337 (Total estimated savings of Sertraline HCl 50 MG Tablet 500.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Sertraline HCl 50 MG Tablet 500.000 EA, page 9 of the report PDF) |
|---|
| Atorvastatin Calcium 20 MG Tablet 500.000 EACardiovascular Agents - Antihyperlipidemics | 00378395105 | $56 (Total acquisition cost of Atorvastatin Calcium 20 MG Tablet 500.000 EA, page 9 of the report PDF) | $4,755 (Total estimated savings of Atorvastatin Calcium 20 MG Tablet 500.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Atorvastatin Calcium 20 MG Tablet 500.000 EA, page 9 of the report PDF) |
|---|
| Rivaroxaban 20 MG Tablet 30.000 EAHematological Agents - Anticoagulants | 50458057930 | $31 (Total acquisition cost of Rivaroxaban 20 MG Tablet 30.000 EA, page 9 of the report PDF) | $46,579 (Total estimated savings of Rivaroxaban 20 MG Tablet 30.000 EA, page 9 of the report PDF) | 1 (Hospitals that named Rivaroxaban 20 MG Tablet 30.000 EA, page 9 of the report PDF) |
|---|
| Insulin Aspart 100 UNIT/ML Solution 10.000 ML UUEndocrine and Metabolic Agents - Antidiabetics | 00169750111 | $16 (Total acquisition cost of Insulin Aspart 100 UNIT/ML Solution 10.000 ML UU, page 9 of the report PDF) | $12,099 (Total estimated savings of Insulin Aspart 100 UNIT/ML Solution 10.000 ML UU, page 9 of the report PDF) | 1 (Hospitals that named Insulin Aspart 100 UNIT/ML Solution 10.000 ML UU, page 9 of the report PDF) |
|---|